Axington drops plan to acquire Vesta Apex Trading after failing to win shareholders' approval
The deal was to have been the start of its pivot to the medical and consumer wellness sector
Singapore
AXINGTON Inc will not proceed with its proposed S$12 million acquisition of a Malaysia-based medical products distributor, after failing to obtain shareholders' approval for the deal.
In a regulatory filing on Friday, the Catalist-listed firm said conditions for the acquisition of the entire issued and paid-up share capital of Vesta Apex Trading have not been fulfilled or waived by the long-stop date, in particular approval from shareholders.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Far East Orchard acquires 49% stake in UK-based purpose-built student accommodation operator for £17.6 million
Nestle sales growth sputters on US slump, vitamin snags
BNP Paribas beats estimates as lower costs offset trading slump
TikTok ultimatum puts US firms in firing line for China response
Toyota and Nissan pair up with Tencent and Baidu for China AI arms race
BHP targets Anglo American in bid valuing miner at US$39 billion